BIO-key International, Inc.
BKYI
$0.71
-$0.03-3.98%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -27.75% | 48.68% | -26.32% | -19.88% | 18.03% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -27.75% | 48.68% | -26.32% | -19.88% | 18.03% |
| Cost of Revenue | -23.03% | 76.97% | -6.71% | -86.34% | -68.50% |
| Gross Profit | -29.05% | 40.24% | -29.44% | 1,356.44% | 393.30% |
| SG&A Expenses | -12.91% | -13.46% | -23.02% | -14.90% | -9.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.40% | -0.52% | -16.44% | -39.99% | -27.96% |
| Operating Income | -53.72% | 34.47% | -25.88% | 53.46% | 70.47% |
| Income Before Tax | -30.55% | 29.97% | -44.33% | 46.88% | 59.79% |
| Income Tax Expenses | -- | -- | -- | 91.69% | -- |
| Earnings from Continuing Operations | -30.55% | 29.97% | -44.33% | 41.65% | 59.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -30.55% | 29.97% | -44.33% | 41.65% | 59.79% |
| EBIT | -53.72% | 34.47% | -25.88% | 53.46% | 70.47% |
| EBITDA | -69.71% | 36.71% | -33.28% | 54.04% | 74.71% |
| EPS Basic | 62.53% | 80.00% | 50.43% | 89.77% | 87.86% |
| Normalized Basic EPS | 62.56% | 80.00% | 50.41% | 91.19% | 88.87% |
| EPS Diluted | 62.53% | 80.00% | 50.43% | 89.77% | 87.86% |
| Normalized Diluted EPS | 62.56% | 80.00% | 50.41% | 91.19% | 88.87% |
| Average Basic Shares Outstanding | 248.60% | 250.04% | 191.12% | 470.50% | 231.06% |
| Average Diluted Shares Outstanding | 248.60% | 250.04% | 191.12% | 470.50% | 231.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |